Drug targeting to the colon with lectins and neoglycoconjugates
- PMID: 14969755
- DOI: 10.1016/j.addr.2003.10.017
Drug targeting to the colon with lectins and neoglycoconjugates
Abstract
Targeting of drugs to specific sites of action provides several advantages over non-targeted drugs. These include the prevention of side effects of drugs on healthy tissues and enhancement of drug uptake by targeted cells. This review will cover traditional approaches of colon drug targeting as well as the use of lectins and neoglycoconjugates for the targeted delivery. Direct and reverse targeting strategies, potential molecular targets and targeting moieties for colon drug delivery, targeted drug delivery systems (DDS) for colon delivery, anticancer DDS targeted to colon cancer are examined. Directions of future development are discussed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
